International meeting focused on Hepatitis B virus research
2024 International Meeting on the Molecular Biology of Hepatitis B Viruses (International HBV Meeting)
This study is bringing together scientists from around the world to share ideas and discoveries about Hepatitis B, with a focus on finding better treatments, especially by including diverse voices in the conversation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hepatitis B Foundation NIH-funded |
| Lab location | 1 site (Doylestown, United States) |
| Project ID | NIH-10999579 on NIH RePORTER |
What this research studies
This research involves organizing an international meeting that brings together scientists and researchers to discuss advancements in understanding and treating Hepatitis B virus (HBV) infections. The meeting aims to foster collaboration and knowledge sharing among established and early career researchers, particularly those from underrepresented backgrounds. It will cover topics such as infection mechanisms, disease progression, and potential therapeutic strategies for chronic HBV. By facilitating discussions and presentations, the meeting seeks to accelerate the development of new treatments for HBV.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals affected by chronic Hepatitis B or those interested in the latest advancements in HBV treatment.
Not a fit: Patients who are not affected by Hepatitis B or who are not involved in research or clinical trials related to HBV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve outcomes for patients with chronic Hepatitis B infections.
How similar studies have performed: Previous international meetings on similar topics have successfully fostered collaboration and led to advancements in the understanding and treatment of Hepatitis B.
Where this research is happening
Doylestown, United States
- Hepatitis B Foundation — Doylestown, United States (Active)
Researchers
- Principal investigator: Ploss, Alexander — Hepatitis B Foundation
- Study coordinator: Ploss, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.